Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial

Younossi ZM, Stepanova M, Feld J, Zeuzem S, Jacobson I, Agarwal K, et al. Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial. Journal of Hepatology. 2016;65(1):33 - 39.

Publication Type:

Journal Article

Source:

Journal of Hepatology, Volume 65, Issue 1, p.33 - 39 (2016)

Keywords:

HCV, PRO, SOF/VEL
Top